Sign in to fuzzto save your conversations, follow your research and come back anytime.
Tata Chemicals
SectorChemicals
Tata Chemicals Limited is a global sustainable chemistry solutions company and part of the Tata Group. It operates in two main segments: Basic Chemistry Products and Specialty Products. The Basic Chemistry segment produces inorganic chemicals like soda ash, salt, and sodium bicarbonate for industries such as glass, detergents, food, and pharmaceuticals. The Specialty Products segment includes specialty silica, prebiotics, and agri-inputs. The company has manufacturing facilities in India, USA, UK, and Kenya. It is a major producer of soda ash and sodium bicarbonate globally and a market leader in India's branded iodized salt segment. Tata Chemicals also offers consumer products like Tata Salt and Tata Sampann food products. Through its subsidiary Rallis India, the company has a strong presence in crop protection and seeds business. Tata Chemicals is focused on innovation, with research centers working on areas such as nanotechnology and biotechnology.
In the news
SC stays coercive action against Tata Chemicals over Gulf of Kutch
Tata stocks surge 13% on IPO buzz, SP Group bonds offered at premium
Tata stocks crash ₹52,600 crore as Trusts-Sons rift deepens
Tata Chemicals: The Dual Catalyst Driving a 20% Surge
Tata Chemicals rebounds 14% from low, up 15% on listing hopes despite earnings pressure
Tata Chemicals' Kenya Crisis: A $586 Crore Regulatory Storm
Tata Chemicals faces Kenya exit as President Ruto revokes concession
Tata Chemicals secures $21.16M soda ash contracts through Searles Valley acquisition
Tata Sons Classified as Upper-Layer NBFC, Shares Rally 7%
Tata Chemicals Q1: Motilal Oswal Maintains Neutral Rating
Tata Chemicals Q1: Net loss of ₹17 cr, shares fall 2.41%
Tata Chemicals surges 6% on RBI NBFC rule as Tata Sons listing hopes rise
39 stocks go ex-dividend next week: Infosys, Adani Enterprises lead
Tata Chemicals: The ₹21,000 Crore Paradox
Tata Group Companies Offer ₹47.65 Dividend in June 2026
Tata Chemicals Q4 loss widens to ₹2,132 cr, approves ₹100 cr salt expansion
Indian Markets Set for Lower Opening Amid Middle East Tensions
Tata Chemicals surges 13%, Piramal Finance climbs 12.5% on heavy volumes
Tata Sons IPO buzz drives 19% rally in Tata stocks
Tata Chemicals, Tata Investment Corp shares surge 12% on IPO buzz
The Quarter story
The two most recent quarterly results, compared side-by-side.
India and Rallis lead a strong earnings recovery, offsetting persistent losses in the US and UK.
India PAT grew from ₹99 Cr to ₹343 Cr from Q2 2024-25 to Q1 2026-27 — strong domestic earnings drive recovery
US PAT fell from ₹65 Cr to ₹-130 Cr from Q2 2024-25 to Q1 2026-27 — regional headwinds drag down group profits
Standalone EBITDA margin expanded from 14% to 28% from Q2 2024-25 to Q1 2026-27 — tight cost control boosts core profitability
UK PAT worsened from ₹-59 Cr to ₹-68 Cr from Q2 2024-25 to Q1 2026-27 — persistent operational losses continue
Rallis PAT recovered from ₹-32 Cr to ₹125 Cr from Q4 2024-25 to Q1 2026-27 — agri-business segment returns to profit
Kenya PAT dropped from ₹40 Cr to ₹-7 Cr from Q2 2024-25 to Q1 2026-27 — East Africa margins face severe pressure
Consolidated revenue rebounded from ₹3,509 Cr to ₹4,255 Cr from Q4 2024-25 to Q1 2026-27 — top-line stabilizes after mid-year dip
Net debt rose from ₹5,329 Cr to ₹5,692 Cr from Q3 2024-25 to Q1 2026-27 — elevated leverage requires monitoring
Company insights, generated from the most recent coverage.
Noel Tata voted against both Chandrasekaran's third term and the listing decision on Sept 17, 2026 — the clearest signal that the fight is over who controls strategy: management or the majority shareholder.
Noel Tata floated monetising enough SP shares for at least ₹25,000 crore, possibly via NCLT capital reduction — an alternative to listing that would give the group's hidden stake a market price without an IPO.
The 4:1 board vote on Sept 17, 2026 puts the Tata Sons board and the 66%-holding Trusts on opposite sides — a reversal of the 2016 Mistry episode, when the board backed the Trusts' chairman.